Seeking Alpha

Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)

Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)
Comments (1)
  • This qt was a test, as patients moved from treatment every month to every other month, how would revenue growth be impacted, looks like REGN came through with flying colors
    14 Feb 2013, 08:00 AM Reply Like
DJIA (DIA) S&P 500 (SPY)